Cargando…
Animal Models of Chorioamnionitis: Considerations for Translational Medicine
Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a he...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032938/ https://www.ncbi.nlm.nih.gov/pubmed/35453561 http://dx.doi.org/10.3390/biomedicines10040811 |
_version_ | 1784692768027705344 |
---|---|
author | Raia-Barjat, Tiphaine Digonnet, Margaux Giraud, Antoine Ayash, Taghreed Vancolen, Seline Benharouga, Mohamed Chauleur, Céline Alfaidy, Nadia Sébire, Guillaume |
author_facet | Raia-Barjat, Tiphaine Digonnet, Margaux Giraud, Antoine Ayash, Taghreed Vancolen, Seline Benharouga, Mohamed Chauleur, Céline Alfaidy, Nadia Sébire, Guillaume |
author_sort | Raia-Barjat, Tiphaine |
collection | PubMed |
description | Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a heavy burden of multiorgan morbidities in the offspring. Unfortunately, chorioamnionitis is still missing effective biomarkers and early placento- as well as feto-protective and curative treatments. This review summarizes recent advances in the understanding of the underlying mechanisms of chorioamnionitis and subsequent impacts on the pregnancy outcome, both during and beyond gestation. This review also describes relevant and current animal models of chorioamnionitis used to decipher associated mechanisms and develop much needed therapies. Improved knowledge of the pathophysiological mechanisms underpinning chorioamnionitis based on preclinical models is a mandatory step to identify early in utero diagnostic biomarkers and design novel anti-inflammatory interventions to improve both maternal and fetal outcomes. |
format | Online Article Text |
id | pubmed-9032938 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90329382022-04-23 Animal Models of Chorioamnionitis: Considerations for Translational Medicine Raia-Barjat, Tiphaine Digonnet, Margaux Giraud, Antoine Ayash, Taghreed Vancolen, Seline Benharouga, Mohamed Chauleur, Céline Alfaidy, Nadia Sébire, Guillaume Biomedicines Review Preterm birth is defined as any birth occurring before 37 completed weeks of gestation by the World Health Organization. Preterm birth is responsible for perinatal mortality and long-term neurological morbidity. Acute chorioamnionitis is observed in 70% of premature labor and is associated with a heavy burden of multiorgan morbidities in the offspring. Unfortunately, chorioamnionitis is still missing effective biomarkers and early placento- as well as feto-protective and curative treatments. This review summarizes recent advances in the understanding of the underlying mechanisms of chorioamnionitis and subsequent impacts on the pregnancy outcome, both during and beyond gestation. This review also describes relevant and current animal models of chorioamnionitis used to decipher associated mechanisms and develop much needed therapies. Improved knowledge of the pathophysiological mechanisms underpinning chorioamnionitis based on preclinical models is a mandatory step to identify early in utero diagnostic biomarkers and design novel anti-inflammatory interventions to improve both maternal and fetal outcomes. MDPI 2022-03-30 /pmc/articles/PMC9032938/ /pubmed/35453561 http://dx.doi.org/10.3390/biomedicines10040811 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Raia-Barjat, Tiphaine Digonnet, Margaux Giraud, Antoine Ayash, Taghreed Vancolen, Seline Benharouga, Mohamed Chauleur, Céline Alfaidy, Nadia Sébire, Guillaume Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title | Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title_full | Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title_fullStr | Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title_full_unstemmed | Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title_short | Animal Models of Chorioamnionitis: Considerations for Translational Medicine |
title_sort | animal models of chorioamnionitis: considerations for translational medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032938/ https://www.ncbi.nlm.nih.gov/pubmed/35453561 http://dx.doi.org/10.3390/biomedicines10040811 |
work_keys_str_mv | AT raiabarjattiphaine animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT digonnetmargaux animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT giraudantoine animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT ayashtaghreed animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT vancolenseline animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT benharougamohamed animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT chauleurceline animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT alfaidynadia animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine AT sebireguillaume animalmodelsofchorioamnionitisconsiderationsfortranslationalmedicine |